Clinical pathway for psychosomatic disorders in pregnancy and puerperium (2017)

doi:10.3877/cma.j.issn.1673-5250.2017.06.004

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2017, Vol. 13 ›› Issue (06): 640 -644. doi: 10.3877/cma.j.issn.1673-5250.2017.06.004

Special Issue: ；

Standard ? Proposal ? Guideline

Clinical pathway for psychosomatic disorders in pregnancy and puerperium (2017)

Feng Qin¹^,^†(), Lijuan Li², Lijun Xiao³^,^†(), Lixin Zhang⁴, Zhengmei Gao⁵, Haiying Lan⁶, Yingli Wang⁷, Juanjuan Zhao⁸, Ailing Wang⁹, Daihua Han¹⁰, Yuehua Wang¹¹

^1. General Research Group of National Maternal Physical and Mental Health Clinic, Beijing 100142, China
^2. Maternal and Child Health Center, Chinese Center for Disease Control and Prevention, Beijing 100098, China
^3. Scientific Research Office, Bayi Children′s Hospital, General Hospital of Beijing Military Region, Beijing 100700, China
^4. Study Base of Psychosomatic Health Outpatient for Pregnant Women, Dagang Maternal and Child Care Center, Binhai New Area, Tianjin 300270, China
^5. Study Base of Psychosomatic Health Outpatient for Pregnant Women, Ling′an Maternal and Child Health Care and Family Planning Service Center, Hangzhou 311300, Zhejiang Province, China
^6. Study Base of Psychosomatic Health Outpatient for Pregnant Women, Yuexiu District Maternal and Child Care Center, Guangzhou 510055, Guangdong Province, China
^7. Study Base of Psychosomatic Health Outpatient for Pregnant Women, Yantaishan Hospital, Yantai, Yantai 264000, Shandong Province, China
^8. Study Base of Psychosomatic Health Outpatient for Pregnant Women, Xinjiang Uygur Autonomous Region Maternal and Child Health Care Hospital, Urumchi 830001, Xinjiang Uygur Autonomous Region, China
^9. Study Base of Psychosomatic Health Outpatient for Pregnant Women, Jiaozuo Maternal and Child Health Care Hospital, Jiaozuo 454150, Henan Province, China
^10. Study Base of Psychosomatic Health Outpatient for Pregnant Women, Shuangliu Maternal and Child Health Care Hospital, Chengdu 610200, Sichuan Province, China
^11. Study Base of Psychosomatic Health Outpatient for Pregnant Women, Debao County Maternal and Child Health Care Hospital, Baise 533700, Guangxi Zhuang Autonomous Region, China

Received:2017-11-03 Revised:2017-11-25 Published:2017-12-01
Corresponding author: Feng Qin, Lijun Xiao
About author:
Corresponding authors: Qin Feng, Email: bgs_010@126.com
Xiao Lijun, Email: ycf@vip.126.com

HTML ( ) PDF ( )

Psychosomatic disorders (PSD) in pregnancy and puerperium is defined as functional somatization disorders in pregnant and puerperal woman induced by mental health problems, which may cause pregnancy-related diseases, resulting in impaired fetal normal development as well as premature delivery, miscarriage and postpartum complications, and severely affect the delivery mode, labor process and health of newborns. The causes of above mentioned adverse effects are mental health problems of pregnant and puerperal women, which are clinically manifested as PSD in pregnancy and puerperium, including 12 somatic dysfunction symptoms as frequent dreaming, restless sleep, difficulty falling asleep, frequent urination, nausea, vomiting, gastric distention, constipation, chest distress, palpitation, dry mouth and sore muscle. The analysis of clinical data on large number of samples from multiple study bases of psychosomatic health outpatients for pregnant women across China performed by general research group of National Maternal Physical and Mental Health Clinic showed that, the multidisciplinary cooperation mode of physiological regulation, psychological adjustment and music conditioning (PPM) had a clinical effective rate of 92.23% and 99.48% in resolving somatic dysfunction symptoms and high-risk factors of anxiety and depression in pregnant and puerperal women with PSD, respectively, and a recovery rate of 91.50% 2 months after cure in Psychosomatic Health Outpatient for Pregnant Women. This series of studies suggested that PSD in pregnancy and puerperium is controllable and curable. By conducting in depth studies on " maternal psychosomatic health clinic and establishment and application of PSD in pregnancy management system" , the general research group developed the 2017 Clinical Pathway for PSD in Pregnancy and Puerperium based on results of previous related studies, providing clinical standards for further developmental studies.

Key words: Psychophysiologic disorders, Somatoform disorders, Clinical pathways, Pregnant women, Puerpera

表1 《孕产期心身障碍临床路径(2017版)》表单

适用对象：①多梦、易醒、入睡困难、尿频、恶心、呕吐、胃胀、便秘、胸闷、心悸、口干、肌肉酸痛12项躯体功能障碍症状以1项或多项持续或有规律发生≥7 d；②HAMA总分为7～13分；③HRV监测报告显示，反映受试者ANS功能状态的坐标，位于ANS功能状态图的交感或副交感活跃区
孕(产)妇姓名：__________　年龄：______　孕次：______			产次：______　孕龄：______孕周(或)产后：______天		门诊号：______
门诊治疗日期：________年______月______日至________年______月______日					门诊标准疗程：6次
治疗时间	治疗第1次		治疗第2～5次		治疗完成当日
主要诊疗工作	□详细询问病史，完善检查 □初步诊断，确定治疗方案 □向孕产妇及其家属交代病情 □开具诊断报告及检查单 □应用首次PPM＋孕产期健康教育治疗方案治疗 □上级医师指导治疗(必要时) □出具家庭调理方案和心理调节鼓励方案 □完成首次病程记录及病历记录		□随诊检查家庭调理记录单，评估家庭调理疗效和了解孕产妇近期情况 □向孕产妇及其家属介绍诊疗情况 □审查门诊治疗室临床护理报告单，认真分析重点问题 □应用第2～5次PPM＋孕产期健康教育治疗方案治疗 □门诊多学科合作小组疑难病例讨论(必要时) □多学科专家联合，包括远程会诊(必要时) □出具家庭调理方案和心理调节鼓励方案 □完成病程记录		□随诊检查家庭调理记录单，评估家庭调理疗效和了解孕产妇近期情况 □审查门诊治疗室临床护理报告单，认真分析重点问题 □应用第6次PPM＋孕产期健康教育治疗方案治疗 □复诊并开具复诊单 □向孕产妇及其家属介绍康复情况 □出具治疗后10周家庭调理方案 □出具治疗后10周随访方案 □完成病历
重要医嘱	长期医嘱：		长期医嘱：		长期医嘱：
?	□按照医嘱完成PPM家庭调理和填写家庭调理记录单 □按照医嘱执行家庭心理调节鼓励方案 □其他孕产期心身健康注意事项		□按照医嘱完成PPM家庭调理和填写家庭调理记录单 □按照医嘱执行家庭心理调节鼓励方案 □明确每次随诊和治疗时间 □其他孕产期心身健康注意事项		□按照医嘱完成治疗后10周的家庭调理，并填写家庭调理记录单 □认真配合门诊医护人员随访 □门诊复查(必要时) □其他孕产期心身健康注意事项
?	临时医嘱：		临时医嘱：		?
?	□根据首次治疗情况及家庭调理方案下达家庭调理医嘱 □明确下次随诊和治疗时间		□根据每次治疗中的临床重、难点及患者个性化问题，下达门诊治疗室临床应对措施医嘱 □根据每阶段门诊临床问题及家庭调理问题，下达门诊随访室随访医嘱(必要时) □根据每次治疗和家庭调理情况，以及躯体障碍症状变化情况，下达家庭调理医嘱		?
主要护理工作	□介绍门诊环境 □协助完成辅助检查 □首次PPM＋孕产期健康教育临床护理 □观察孕产妇对治疗的临床适应性 □填写临床护理报告手册 □告知随诊和治疗时间及地点		□协助完成随诊 □第2～5次PPM＋孕产期健康教育临床护理 □观察孕产妇对治疗的临床适应性 □严格执行临床医嘱 □填写临床护理报告手册 □告知随诊和治疗时间及地点		□第6次PPM＋孕产期健康教育临床护理 □正确执行临床医嘱 □协助完成复诊 □引导办理治疗结束手续 □治疗结束后的孕产期健康教育
变异记录	□无		□无		□无
?	□有，原因：		□有，原因：		□有，原因：
?	?	1.	?	1.	?	1.
?	?	2.	?	2.	?	2.
护士签名	?		?		?
医师签名	?		?		?

表1 《孕产期心身障碍临床路径(2017版)》表单

适用对象：①多梦、易醒、入睡困难、尿频、恶心、呕吐、胃胀、便秘、胸闷、心悸、口干、肌肉酸痛12项躯体功能障碍症状以1项或多项持续或有规律发生≥7 d；②HAMA总分为7～13分；③HRV监测报告显示，反映受试者ANS功能状态的坐标，位于ANS功能状态图的交感或副交感活跃区
孕(产)妇姓名：__________　年龄：______　孕次：______			产次：______　孕龄：______孕周(或)产后：______天		门诊号：______
门诊治疗日期：________年______月______日至________年______月______日					门诊标准疗程：6次
治疗时间	治疗第1次		治疗第2～5次		治疗完成当日
主要诊疗工作	□详细询问病史，完善检查 □初步诊断，确定治疗方案 □向孕产妇及其家属交代病情 □开具诊断报告及检查单 □应用首次PPM＋孕产期健康教育治疗方案治疗 □上级医师指导治疗(必要时) □出具家庭调理方案和心理调节鼓励方案 □完成首次病程记录及病历记录		□随诊检查家庭调理记录单，评估家庭调理疗效和了解孕产妇近期情况 □向孕产妇及其家属介绍诊疗情况 □审查门诊治疗室临床护理报告单，认真分析重点问题 □应用第2～5次PPM＋孕产期健康教育治疗方案治疗 □门诊多学科合作小组疑难病例讨论(必要时) □多学科专家联合，包括远程会诊(必要时) □出具家庭调理方案和心理调节鼓励方案 □完成病程记录		□随诊检查家庭调理记录单，评估家庭调理疗效和了解孕产妇近期情况 □审查门诊治疗室临床护理报告单，认真分析重点问题 □应用第6次PPM＋孕产期健康教育治疗方案治疗 □复诊并开具复诊单 □向孕产妇及其家属介绍康复情况 □出具治疗后10周家庭调理方案 □出具治疗后10周随访方案 □完成病历
重要医嘱	长期医嘱：		长期医嘱：		长期医嘱：
?	□按照医嘱完成PPM家庭调理和填写家庭调理记录单 □按照医嘱执行家庭心理调节鼓励方案 □其他孕产期心身健康注意事项		□按照医嘱完成PPM家庭调理和填写家庭调理记录单 □按照医嘱执行家庭心理调节鼓励方案 □明确每次随诊和治疗时间 □其他孕产期心身健康注意事项		□按照医嘱完成治疗后10周的家庭调理，并填写家庭调理记录单 □认真配合门诊医护人员随访 □门诊复查(必要时) □其他孕产期心身健康注意事项
?	临时医嘱：		临时医嘱：		?
?	□根据首次治疗情况及家庭调理方案下达家庭调理医嘱 □明确下次随诊和治疗时间		□根据每次治疗中的临床重、难点及患者个性化问题，下达门诊治疗室临床应对措施医嘱 □根据每阶段门诊临床问题及家庭调理问题，下达门诊随访室随访医嘱(必要时) □根据每次治疗和家庭调理情况，以及躯体障碍症状变化情况，下达家庭调理医嘱		?
主要护理工作	□介绍门诊环境 □协助完成辅助检查 □首次PPM＋孕产期健康教育临床护理 □观察孕产妇对治疗的临床适应性 □填写临床护理报告手册 □告知随诊和治疗时间及地点		□协助完成随诊 □第2～5次PPM＋孕产期健康教育临床护理 □观察孕产妇对治疗的临床适应性 □严格执行临床医嘱 □填写临床护理报告手册 □告知随诊和治疗时间及地点		□第6次PPM＋孕产期健康教育临床护理 □正确执行临床医嘱 □协助完成复诊 □引导办理治疗结束手续 □治疗结束后的孕产期健康教育
变异记录	□无		□无		□无
?	□有，原因：		□有，原因：		□有，原因：
?	?	1.	?	1.	?	1.
?	?	2.	?	2.	?	2.
护士签名	?		?		?
医师签名	?		?		?

[1]	郜正美，陈双燕，吴孟芳，等. 全国多中心孕产妇心身健康门诊9 712例孕妇孕产期心身障碍发病率调查研究[J]. 中国卫生标准管理，2017, 8(18): 31-34.
[2]	张立新，孙静，陈俊梅，等. 多学科合作诊疗系统治疗孕妇心理问题诱发的躯体功能障碍临床回顾性研究[J]. 中国妇幼健康研究，2017, 28(5): 514-516.
[3]	蓝海英，曾妍芳，丁颖，等. 应用PPM多学科合作诊疗系统治疗孕产期心身障碍对孕妇焦虑抑郁高危因素影响的调查研究[J]. 中国卫生标准管理，2017, 8(19): 29-31.
[4]	张立新，陈俊梅，孙静，等. 应用PPM多学科合作诊疗系统治疗孕产期心身障碍病愈2个月后康复状况调查研究[J]. 中国卫生标准管理，2017, 8(18): 48-50.
[5]	秦峰，徐宝良，张立新，等. "孕产妇心身健康门诊"研究进展[J]. 中国卫生标准管理，2017, 8(4): 17-20.
[6]	张红梅，吴爱勤，徐英，等. 影响产前孕妇血压及胎心率的心理社会因素[J]. 中国心理卫生杂志，2004, 18(6): 381.
[7]	王东林，吴彩云，吴爱勤. 躯体化障碍与抑郁症的生物学特征及心理社会因素比较[J]．临床精神医学杂志，2000, 10(2): 68-70.
[8]	沈鑫华，吴爱勤，陈加美，等. 广泛焦虑障碍的下丘脑-垂体-肾上腺轴及PRL研究[J]．中国神经精神疾病杂志，2002, 28(2): 129-130.
[9]	吴文源. 焦虑障碍防治指南[M]. 北京：人民卫生出版社，2010: 1-272.
[10]	丁辉，陈林，邸晓兰. 产后抑郁障碍防治指南的专家共识(基于产科和社区医生)[J]．中国妇产科临床杂志，2014, 15(6): 572-576.
[11]	中华心血管病杂志编委会心率变异性对策专题组. 心率变异性检测临床应用的建议[J]. 中华心血管病杂志，1998, 26(4): 252-255.
[12]	阎克乐，张文彩，张月娟，等. 心率变异性在心身疾病和情绪障碍研究中的应用[J]．心理科学进展，2006, 14(2): 261-265.
[13]	胡华，吴爱勤. 焦虑症与心脏自主神经功能紊乱的相关研究[J]. 山东精神医学，2006, 19(2): 154-156.
[14]	胡华，吴爱勤. 焦虑症的特质焦虑水平与心率变异性相关研究[J]. 临床精神医学杂志，2007, 17(2): 85-87.
[15]	胡华，吴爱勤. 焦虑症与心率变异性的相关研究[J]. 国际精神病学杂志，2007, 34(4): 239-241.
[16]	张谦，栾彤，沈洁，等. 焦虑抑郁患者的心率变异性特点[J]. 苏州大学学报(医学版), 2008, 28(5): 804-806.
[17]	徐阿红，吴爱勤. 抑郁症躯体症状的研究进展[J]. 神经疾病与精神卫生，2009, 9(4): 354-356.
[18]	徐阿红，吴爱勤，卢卫红，等. 心理应激对以躯体症状为主的抑郁症患者自主神经影响的研究[J]. 精神医学杂志，2011, 24(3): 172-175.
[19]	吴爱勤. 心身疾病新的评估策略：心身医学研究诊断标准[J]. 医学与哲学(临床决策论坛版), 2012, 33(1): 8-10.
[20]	吴爱勤. 心身医学分类诊断评估策略[J]. 实用医院临床杂志，2015, 12(6): 1-6.

[1]	Jingyu Qian, Mingming Zheng. Interpretation of the Italian guidelines on non-invasive and invasive prenatal diagnosis：executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology（SIGO）[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 486-492.
[2]	Xialin Li, Fang He. Risk assessment and early warning system for postpartum hemorrhage[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 498-503.
[3]	Ziyang Liu, Jianjian Cui, Yin Zhao. Current research status on obstetric disseminated intravascular coagulation and its scoring system[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 511-518.
[4]	Fanying Zeng, Jie Ruan, Xinghui Liu, Guolin He. Current status of perinatal medicine advances under the new reproductive situation and coping strategies in prenatal care[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 519-524.
[5]	Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[6]	Rong Huang, Ziyu Liang, Wenjin Qi. Expression and significance of NLRP3 inflammasome in serum of pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 540-548.
[7]	Xia He, Rong Huang, Wenjin Qi. High-throughput sequencing study on the abundance of placenta and fetal membrane flora in pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 549-555.
[8]	Jiangyan Xie, Yafei Wang, Fang He. Pregnancy complicated with thrombotic thrombocytopenic purpura：two cases report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 556-563.
[9]	Xiaoyan Han, Hua Yang. Relationship between low level of serum placental growth factor in the second trimester pregnancy women and adverse fetal prognosis[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 398-402.
[10]	Jiali Du, Rui Bao, Chunhong Qiao, Wei Han. Construction of a prediction model for adverse pregnancy outcomes after emergency cervical cerclage in pregnant women with cervical incompetence during the second trimester[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 403-409.
[11]	Tingting Xu, Yongchi Zhan, Xiaodong Wang, Xiaodong Wang. Perinatal outcomes of fetomaternal hemorrhage syndrome pregnant women with sinusoidal fetal heart tracing[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 382-389.
[12]	Juan Tan, Jianxin Tan, Binbin Shao, Yan Wang, Zhengfeng Xu. Current research status on non-invasive prenatal testing for fetal with single gene inheritance diseases[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 245-250.
[13]	Hui Hua, Chenying Xu, Jinfeng Liu. Effect of pelvic floor muscle training timing on postpartum pelvic floor muscle tension and sexual function of elderly primiparae[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 284-291.
[14]	Xue Lin, Meng Chen, Meilin Yang, Xinghui Liu, Hongyu Zhou. Perinatal outcomes of pregnant women with myasthenia gravis and risk factors for disease exacerbation of myasthenia gravis[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 125-132.
[15]	Xiaorong Peng, Wei Mo, Qin Li, Yaqin Wu, Lan Li. Knowledge, attitude and practice of venous thromboembolism prevention and influencing factors among pregnant women[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2024, 12(03): 274-280.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export

Clinical pathway for psychosomatic disorders in pregnancy and puerperium (2017)

模态框（Modal）标题

Please choose a citation manager

Content to export

Clinical pathway for psychosomatic disorders in pregnancy and puerperium (2017)